.png){kind=logo}
Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Sep 16, 2025After three years, most insulin was delivered automatically by the system, and those who used the recommended optimal settings experienced the greatest benefits.GALWAY, Ireland – September 16 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today presented compelling real-world evidence demonstrating that the MiniMed™ 780G...
Sep 11, 2025Medtronic plc, a global leader in medical technology, announced it will present new data on its MiniMed™ 780G system at the upcoming European Association for the Study of Diabetes (EASD) 61st...
Sep 2, 2025Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system...
- Jul 21, 2025
Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the MiniMed™ 780G system for use by...
- Jul 8, 2025
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended...
Jun 18, 2025Medtronic plc, a global leader in healthcare technology, is partnering with professional tennis player Alexander Zverev and his foundation to elevate global awareness of type 1 diabetes. Through...
Jun 12, 2025Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the...
- May 21, 2025Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes business into a new standalone company ("New Diabetes Company"). This...
- Apr 24, 2025
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug Administration (FDA) seeking clearance for an...
Apr 18, 2025Latest approval expands Medtronic CGM portfolio in the U.S.Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync™ sensor for use with the...